As of 2023, over 800 hospitals in India have achieved NABH accreditation, reflecting a growing emphasis on quality healthcare. NABH accreditation is not just a prestigious certification but a comprehensive framework designed to enhance patient...

The Indian pharmaceutical industry is currently investing a lot into innovation in order to keep up with the global competition. Many companies are focusing on development of novel drug delivery systems.

A novel biomarker for alzheimer’s disease in its asymptomatic phase has been discovered in a study that was conducted by the Molecular and Cellular Neurobiotechnology group at the University of Barcelona & the

Meeting the US FDA and EMA standards demands significant investment in quality management systems (QMS), infrastructure and training. Pharmaceutical companies must ensure that their manufacturing facilities, processes, and products comply with CGM...

The pharmaceutical sector in India is on the verge of experiencing a remarkable growth that has never been seen before. And businesses nationwide need to elevate their efforts to explore new paths of innovation and achievement.

The global companion diagnostics market was valued at USD 5.2 billion in 2021 and is anticipated to reach USD 10.3 billion by 2028, reflecting a compound annual growth rate (CAGR) increase of 12.2% between 2021 and 2028.